Bank of New York Mellon Portfolio holdings
Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Kenvue
KVUE
|
+$592M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$432M |
| 3 |
CRH
CRH
|
+$395M |
| 4 |
Invesco S&P 500 Equal Weight ETF
RSP
|
+$231M |
| 5 |
Intel
INTC
|
+$211M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$558M |
| 2 |
Apple
AAPL
|
+$477M |
| 3 |
NVIDIA
NVDA
|
+$462M |
| 4 |
Microsoft
MSFT
|
+$444M |
| 5 |
Eli Lilly
LLY
|
+$299M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.42% |
| 2 | Healthcare | 12.89% |
| 3 | Financials | 11.48% |
| 4 | Consumer Discretionary | 9.75% |
| 5 | Industrials | 8.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2676
iShares iBonds Dec 2032 Term Corporate ETF
IBDX
$1.73B
| $2.54M | ﹤0.01% |
108,310
+3,672
| +4% | +$88.7K |
|
2677
First Trust Dow Jones Internet Index Fund ETF
FDN
$5.38B
| $2.53M | ﹤0.01% |
15,838
+3,981
| +34% | +$662K |
|
|
LAND
2678
Gladstone Land Corp
LAND
$358M
| $2.53M | ﹤0.01% |
177,585
-452
| -0.3% | -$7.2K |
|
2679
WisdomTree Emerging Markets High Dividend Fund
DEM
$3.97B
| $2.53M | ﹤0.01% |
+67,400
| New | +$2.62M |
|
2680
Target Hospitality
TH
$1.74B
| $2.53M | ﹤0.01% |
159,046
-2,110
| -1% | -$29.8K |
|
2681
Opko Health
OPK
$1.03B
| $2.52M | ﹤0.01% |
1,577,829
-10,433
| -0.7% | -$19K |
|
2682
Portillo's
PTLO
$374M
| $2.52M | ﹤0.01% |
163,609
+17,744
| +12% | +$347K |
|
2683
iShares iBonds Dec 2029 Term Corporate ETF
IBDU
$4.07B
| $2.51M | ﹤0.01% |
114,815
+7,687
| +7% | +$171K |
|
|
NVRO
2684
DELISTED
NEVRO CORP.
NVRO
| $2.51M | ﹤0.01% |
130,533
+7,945
| +6% | +$169K |
|
2685
Skyward Specialty Insurance
SKWD
$2.42B
| $2.5M | ﹤0.01% |
91,346
+61,772
| +209% | +$1.54M |
|
2686
iShares iBonds Dec 2030 Term Corporate ETF
IBDV
$3.3B
| $2.5M | ﹤0.01% |
122,443
+8,914
| +8% | +$186K |
|
|
VERV
2687
DELISTED
Verve Therapeutics
VERV
| $2.48M | ﹤0.01% |
187,192
+407
| +0.2% | +$6.55K |
|
2688
iRadimed
IRMD
$1.11B
| $2.46M | ﹤0.01% |
55,540
+1,389
| +3% | +$64.5K |
|
2689
Costamare
CMRE
$1.77B
| $2.46M | ﹤0.01% |
255,755
-13,919
| -5% | -$142K |
|
|
EQRX
2690
DELISTED
EQRx, Inc. Common Stock
EQRX
| $2.46M | ﹤0.01% |
1,108,234
+125,105
| +13% | +$268K |
|
2691
Editas Medicine
EDIT
$433M
| $2.45M | ﹤0.01% |
314,234
+39,076
| +14% | +$335K |
|
2692
Perimeter Solutions
PRM
$5.55B
| $2.45M | ﹤0.01% |
539,130
-2,895
| -0.5% | -$16.1K |
|
2693
iShares Morningstar Growth ETF
ILCG
$3.29B
| $2.44M | ﹤0.01% |
40,986
-2,536
| -6% | -$158K |
|
|
PLL
2694
DELISTED
Piedmont Lithium
PLL
| $2.44M | ﹤0.01% |
61,396
-5,097
| -8% | -$248K |
|
|
ACCD
2695
DELISTED
Accolade Inc
ACCD
| $2.43M | ﹤0.01% |
230,092
+6,069
| +3% | +$79.6K |
|
|
MTTR
2696
DELISTED
Matterport, Inc. Class A Common Stock
MTTR
| $2.43M | ﹤0.01% |
1,121,653
-23,283
| -2% | -$65.3K |
|
2697
Franklin Covey
FC
$229M
| $2.43M | ﹤0.01% |
56,673
-1,026
| -2% | -$45.5K |
|
2698
i3 Verticals
IIIV
$319M
| $2.43M | ﹤0.01% |
114,906
+1,749
| +2% | +$40.5K |
|
|
SPNS
2699
DELISTED
Sapiens International
SPNS
| $2.41M | ﹤0.01% |
84,883
-2,069
| -2% | -$59.2K |
|
2700
Arcturus Therapeutics
ARCT
$234M
| $2.41M | ﹤0.01% |
94,427
+3,587
| +4% | +$110K |
|
Similar funds
Bank of New York Mellon's Q3 2023 Portfolio in Review
As of Q3 2023, Bank of New York Mellon held 4,503 positions worth $455B, down 4.5% from $476B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Bank of New York Mellon's Q3 2023 filing shows 126 new, 1,681 increased, 2,220 reduced and 160 closed positions. Its largest new stake was Invesco S&P 500 Quality ETF: 1,449,432 shares worth $72.5M. The largest sale was ExxonMobil, an estimated $558M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Healthcare and Financials.
- Bank of New York Mellon's largest Q3 2023 buy was Invesco S&P 500 Quality ETF: 1,449,432 shares worth $72.5M.
- Bank of New York Mellon added most to Kenvue in Q3 2023, an estimated $592M increase.
- Bank of New York Mellon's biggest Q3 2023 reduction was ExxonMobil, cutting an estimated $558M.
- Bank of New York Mellon fully exited Life Storage, Inc. in Q3 2023, selling an estimated $131M.
- Bank of New York Mellon's ten largest holdings make up 21% of its $455B portfolio in Q3 2023.
- Bank of New York Mellon opened 126 new positions and closed 160 in Q3 2023.
- Bank of New York Mellon's portfolio value fell 4.5% quarter-over-quarter to $455B.
Based on Bank of New York Mellon's 13F filing for Q3 2023, filed 24 Oct 2023.